Report cover image

Global MET TKIs Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 115 Pages
SKU # APRC20339513

Description

Summary

According to APO Research, The global MET TKIs market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of MET TKIs include Wanbang Biopharmaceuticals, CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Zydus and Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for MET TKIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MET TKIs.
The MET TKIs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global MET TKIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

MET TKIs Segment by Company

Wanbang Biopharmaceuticals
CSPC Pharmaceutical
Asymchem
Shanghai Hutchison Pharmaceuticals
WuXi STA
Haihe Biopharma
Avistone Pharmaceuticals Biotechnology
Zydus
Teva
Pfizer
Novartis
Merck
Genvio Pharma
Exelixis
Everest Pharmaceuticals
Drug International
Cipla
Beacom
BDR Pharma
MET TKIs Segment by Type

Multi-target Inhibitors
Single-target Inhibitors
MET TKIs Segment by Application

Non-small Cell Lung Cancer
Medullary Thyroid Cancer
Other
MET TKIs Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MET TKIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MET TKIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

115 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global MET TKIs Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global MET TKIs Sales Estimates and Forecasts (2020-2031)
1.3 MET TKIs Market by Type
1.3.1 Multi-target Inhibitors
1.3.2 Single-target Inhibitors
1.4 Global MET TKIs Market Size by Type
1.4.1 Global MET TKIs Market Size Overview by Type (2020-2031)
1.4.2 Global MET TKIs Historic Market Size Review by Type (2020-2025)
1.4.3 Global MET TKIs Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America MET TKIs Sales Breakdown by Type (2020-2025)
1.5.2 Europe MET TKIs Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific MET TKIs Sales Breakdown by Type (2020-2025)
1.5.4 South America MET TKIs Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa MET TKIs Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 MET TKIs Industry Trends
2.2 MET TKIs Industry Drivers
2.3 MET TKIs Industry Opportunities and Challenges
2.4 MET TKIs Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by MET TKIs Revenue (2020-2025)
3.2 Global Top Players by MET TKIs Sales (2020-2025)
3.3 Global Top Players by MET TKIs Price (2020-2025)
3.4 Global MET TKIs Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global MET TKIs Major Company Production Sites & Headquarters
3.6 Global MET TKIs Company, Product Type & Application
3.7 Global MET TKIs Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global MET TKIs Market CR5 and HHI
3.8.2 Global Top 5 and 10 MET TKIs Players Market Share by Revenue in 2024
3.8.3 2023 MET TKIs Tier 1, Tier 2, and Tier 3
4 MET TKIs Regional Status and Outlook
4.1 Global MET TKIs Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global MET TKIs Historic Market Size by Region
4.2.1 Global MET TKIs Sales in Volume by Region (2020-2025)
4.2.2 Global MET TKIs Sales in Value by Region (2020-2025)
4.2.3 Global MET TKIs Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global MET TKIs Forecasted Market Size by Region
4.3.1 Global MET TKIs Sales in Volume by Region (2026-2031)
4.3.2 Global MET TKIs Sales in Value by Region (2026-2031)
4.3.3 Global MET TKIs Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 MET TKIs by Application
5.1 MET TKIs Market by Application
5.1.1 Non-small Cell Lung Cancer
5.1.2 Medullary Thyroid Cancer
5.1.3 Other
5.2 Global MET TKIs Market Size by Application
5.2.1 Global MET TKIs Market Size Overview by Application (2020-2031)
5.2.2 Global MET TKIs Historic Market Size Review by Application (2020-2025)
5.2.3 Global MET TKIs Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America MET TKIs Sales Breakdown by Application (2020-2025)
5.3.2 Europe MET TKIs Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific MET TKIs Sales Breakdown by Application (2020-2025)
5.3.4 South America MET TKIs Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa MET TKIs Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Wanbang Biopharmaceuticals
6.1.1 Wanbang Biopharmaceuticals Comapny Information
6.1.2 Wanbang Biopharmaceuticals Business Overview
6.1.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Wanbang Biopharmaceuticals MET TKIs Product Portfolio
6.1.5 Wanbang Biopharmaceuticals Recent Developments
6.2 CSPC Pharmaceutical
6.2.1 CSPC Pharmaceutical Comapny Information
6.2.2 CSPC Pharmaceutical Business Overview
6.2.3 CSPC Pharmaceutical MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSPC Pharmaceutical MET TKIs Product Portfolio
6.2.5 CSPC Pharmaceutical Recent Developments
6.3 Asymchem
6.3.1 Asymchem Comapny Information
6.3.2 Asymchem Business Overview
6.3.3 Asymchem MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Asymchem MET TKIs Product Portfolio
6.3.5 Asymchem Recent Developments
6.4 Shanghai Hutchison Pharmaceuticals
6.4.1 Shanghai Hutchison Pharmaceuticals Comapny Information
6.4.2 Shanghai Hutchison Pharmaceuticals Business Overview
6.4.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio
6.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments
6.5 WuXi STA
6.5.1 WuXi STA Comapny Information
6.5.2 WuXi STA Business Overview
6.5.3 WuXi STA MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 WuXi STA MET TKIs Product Portfolio
6.5.5 WuXi STA Recent Developments
6.6 Haihe Biopharma
6.6.1 Haihe Biopharma Comapny Information
6.6.2 Haihe Biopharma Business Overview
6.6.3 Haihe Biopharma MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Haihe Biopharma MET TKIs Product Portfolio
6.6.5 Haihe Biopharma Recent Developments
6.7 Avistone Pharmaceuticals Biotechnology
6.7.1 Avistone Pharmaceuticals Biotechnology Comapny Information
6.7.2 Avistone Pharmaceuticals Biotechnology Business Overview
6.7.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio
6.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments
6.8 Zydus
6.8.1 Zydus Comapny Information
6.8.2 Zydus Business Overview
6.8.3 Zydus MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zydus MET TKIs Product Portfolio
6.8.5 Zydus Recent Developments
6.9 Teva
6.9.1 Teva Comapny Information
6.9.2 Teva Business Overview
6.9.3 Teva MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva MET TKIs Product Portfolio
6.9.5 Teva Recent Developments
6.10 Pfizer
6.10.1 Pfizer Comapny Information
6.10.2 Pfizer Business Overview
6.10.3 Pfizer MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer MET TKIs Product Portfolio
6.10.5 Pfizer Recent Developments
6.11 Novartis
6.11.1 Novartis Comapny Information
6.11.2 Novartis Business Overview
6.11.3 Novartis MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis MET TKIs Product Portfolio
6.11.5 Novartis Recent Developments
6.12 Merck
6.12.1 Merck Comapny Information
6.12.2 Merck Business Overview
6.12.3 Merck MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck MET TKIs Product Portfolio
6.12.5 Merck Recent Developments
6.13 Genvio Pharma
6.13.1 Genvio Pharma Comapny Information
6.13.2 Genvio Pharma Business Overview
6.13.3 Genvio Pharma MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Genvio Pharma MET TKIs Product Portfolio
6.13.5 Genvio Pharma Recent Developments
6.14 Exelixis
6.14.1 Exelixis Comapny Information
6.14.2 Exelixis Business Overview
6.14.3 Exelixis MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Exelixis MET TKIs Product Portfolio
6.14.5 Exelixis Recent Developments
6.15 Everest Pharmaceuticals
6.15.1 Everest Pharmaceuticals Comapny Information
6.15.2 Everest Pharmaceuticals Business Overview
6.15.3 Everest Pharmaceuticals MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Everest Pharmaceuticals MET TKIs Product Portfolio
6.15.5 Everest Pharmaceuticals Recent Developments
6.16 Drug International
6.16.1 Drug International Comapny Information
6.16.2 Drug International Business Overview
6.16.3 Drug International MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Drug International MET TKIs Product Portfolio
6.16.5 Drug International Recent Developments
6.17 Cipla
6.17.1 Cipla Comapny Information
6.17.2 Cipla Business Overview
6.17.3 Cipla MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Cipla MET TKIs Product Portfolio
6.17.5 Cipla Recent Developments
6.18 Beacom
6.18.1 Beacom Comapny Information
6.18.2 Beacom Business Overview
6.18.3 Beacom MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beacom MET TKIs Product Portfolio
6.18.5 Beacom Recent Developments
6.19 BDR Pharma
6.19.1 BDR Pharma Comapny Information
6.19.2 BDR Pharma Business Overview
6.19.3 BDR Pharma MET TKIs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 BDR Pharma MET TKIs Product Portfolio
6.19.5 BDR Pharma Recent Developments
7 North America by Country
7.1 North America MET TKIs Sales by Country
7.1.1 North America MET TKIs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America MET TKIs Sales by Country (2020-2025)
7.1.3 North America MET TKIs Sales Forecast by Country (2026-2031)
7.2 North America MET TKIs Market Size by Country
7.2.1 North America MET TKIs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America MET TKIs Market Size by Country (2020-2025)
7.2.3 North America MET TKIs Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe MET TKIs Sales by Country
8.1.1 Europe MET TKIs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe MET TKIs Sales by Country (2020-2025)
8.1.3 Europe MET TKIs Sales Forecast by Country (2026-2031)
8.2 Europe MET TKIs Market Size by Country
8.2.1 Europe MET TKIs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe MET TKIs Market Size by Country (2020-2025)
8.2.3 Europe MET TKIs Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific MET TKIs Sales by Country
9.1.1 Asia-Pacific MET TKIs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific MET TKIs Sales by Country (2020-2025)
9.1.3 Asia-Pacific MET TKIs Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific MET TKIs Market Size by Country
9.2.1 Asia-Pacific MET TKIs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific MET TKIs Market Size by Country (2020-2025)
9.2.3 Asia-Pacific MET TKIs Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America MET TKIs Sales by Country
10.1.1 South America MET TKIs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America MET TKIs Sales by Country (2020-2025)
10.1.3 South America MET TKIs Sales Forecast by Country (2026-2031)
10.2 South America MET TKIs Market Size by Country
10.2.1 South America MET TKIs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America MET TKIs Market Size by Country (2020-2025)
10.2.3 South America MET TKIs Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa MET TKIs Sales by Country
11.1.1 Middle East and Africa MET TKIs Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa MET TKIs Sales by Country (2020-2025)
11.1.3 Middle East and Africa MET TKIs Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa MET TKIs Market Size by Country
11.2.1 Middle East and Africa MET TKIs Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa MET TKIs Market Size by Country (2020-2025)
11.2.3 Middle East and Africa MET TKIs Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 MET TKIs Value Chain Analysis
12.1.1 MET TKIs Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 MET TKIs Production Mode & Process
12.2 MET TKIs Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 MET TKIs Distributors
12.2.3 MET TKIs Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.